Analgesics
Antiandrogens
Azvudine
Bromhexine
Budesonide
Colchicine
Conv. Plasma
Curcumin
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Molnupiravir
Monoclonals
Naso/orophar..
Nigella Sativa
Nitazoxanide
Paxlovid
Quercetin
Remdesivir
Thermotherapy
Vitamins
More

Other
Feedback
Home
Top
Results
Abstract
All HCQ studies
Meta analysis
 
Feedback
Home
next
study
previous
study
c19hcq.org COVID-19 treatment researchHCQHCQ (more..)
Melatonin Meta
Metformin Meta
Azvudine Meta
Bromhexine Meta Molnupiravir Meta
Budesonide Meta
Colchicine Meta
Conv. Plasma Meta Nigella Sativa Meta
Curcumin Meta Nitazoxanide Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Quercetin Meta
Fluvoxamine Meta Remdesivir Meta
Hydroxychlor.. Meta Thermotherapy Meta
Ivermectin Meta

All Studies   Meta Analysis    Recent:   

Countries which Primarily Use Antimalarial Drugs As COVID-19 Treatment See Slower Dynamic of Daily Deaths

Izoulet, M., SSRN, doi:10.2139/ssrn.3575899
Apr 2020  
  Post
  Facebook
Share
  Source   PDF   All Studies   Meta AnalysisMeta
Mortality 85% Improvement Relative Risk HCQ for COVID-19  Izoulet et al.  LATE TREATMENT Is late treatment with HCQ beneficial for COVID-19? Retrospective 1,000,000 patients in multiple countries Lower mortality with HCQ (p=0.001) c19hcq.org Izoulet, M., SSRN, April 2020 FavorsHCQ Favorscontrol 0 0.5 1 1.5 2+
HCQ for COVID-19
1st treatment shown to reduce risk in March 2020
 
*, now with p < 0.00000000001 from 411 studies, recognized in 46 countries.
No treatment is 100% effective. Protocols combine treatments. * >10% efficacy, ≥3 studies.
4,300+ studies for 75 treatments. c19hcq.org
Compares the dynamics of daily deaths in the 10 days following the 3rd death in countries using and not using [H]CQ, showing dramatically lower death in [H]CQ countries. This paper does not attempt to account for population age and other differences between the countries and recommends further study.
This study is excluded in the after exclusion results of meta analysis: excessive unadjusted differences between groups.
risk of death, 85.0% lower, RR 0.15, p < 0.001.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Izoulet et al., 21 Apr 2020, retrospective, multiple countries, preprint, 1 author, dosage not specified.
This PaperHCQAll
Abstract: d Countries which Primarily use Antimalarial Drugs as 5 ev iew e COVID-19 Treatment See Slower Dynamic of daily Deaths Maxime Izoulet, CEMI-EHESS, Paris.
{ 'indexed': { 'date-parts': [[2023, 10, 30]], 'date-time': '2023-10-30T17:55:07Z', 'timestamp': 1698688507990}, 'reference-count': 0, 'publisher': 'Elsevier BV', 'content-domain': {'domain': [], 'crossmark-restriction': False}, 'DOI': '10.2139/ssrn.3575899', 'type': 'journal-article', 'created': {'date-parts': [[2020, 4, 16]], 'date-time': '2020-04-16T11:31:03Z', 'timestamp': 1587036663000}, 'source': 'Crossref', 'is-referenced-by-count': 8, 'title': 'Countries which Primarily Use Antimalarial Drugs As COVID-19 Treatment See Slower Dynamic of ' 'Daily Deaths', 'prefix': '10.2139', 'author': [{'given': 'Maxime', 'family': 'Izoulet', 'sequence': 'first', 'affiliation': []}], 'member': '78', 'container-title': 'SSRN Electronic Journal', 'original-title': [], 'language': 'en', 'deposited': { 'date-parts': [[2020, 4, 16]], 'date-time': '2020-04-16T11:31:32Z', 'timestamp': 1587036692000}, 'score': 1, 'resource': {'primary': {'URL': 'https://www.ssrn.com/abstract=3575899'}}, 'subtitle': [], 'short-title': [], 'issued': {'date-parts': [[2020]]}, 'references-count': 0, 'URL': 'http://dx.doi.org/10.2139/ssrn.3575899', 'relation': {}, 'ISSN': ['1556-5068'], 'subject': [], 'published-other': {'date-parts': [[2020]]}, 'container-title-short': 'SSRN Journal', 'published': {'date-parts': [[2020]]}}
Late treatment
is less effective
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit